FDA Approves Unknown Drug — YICHANG HUMANWELL

# FDA Approves ANDA for Yichang Humanwell The FDA has approved ANDA219518 for Yichang Humanwell, marking the company's entry into the U.S. generic drug market and potentially increasing competitive pricing pressure in the approved therapeutic category. The approval strengthens Yichang Humanwell's position as a pharmaceutical manufacturer capable of meeting U.S. regulatory standards and could generate significant revenue from the substantial generic drug market.